ENDRA Life Sciences Inc. (NDRA)
2025-06-30 | |
|---|---|
| Provision for income taxes | - |
| Changes in fair value of warrant liability | 62,112 |
| Other income (expense) | 13,066 |
| Total other expenses | 75,178 |
| Sales and marketing | 68,834 |
| Research and development | 381,061 |
| General and administrative | 851,195 |
| Total operating expenses | 1,301,090 |
| Operating loss | -1,301,090 |
| Loss from operations before income taxes | -1,225,912 |
| Net loss | -1,225,912 |